Nathan Caffo

Nessuna posizione attualmente

57 anni

Health Technology

Consumer Services

Profilo

Nathan Caffo served as the President & Chief Executive Officer at Presage Biosciences, Inc. from 2009 to 2018.
He then worked as the Chief Business Officer at ALX Oncology Holdings, Inc. from 2018 to 2020.
Currently, he is the Chief Business Officer at Candel Therapeutics, Inc. starting from 2020.
Mr. Caffo completed his undergraduate degree at The Pennsylvania State University.

Precedenti posizioni note di Nathan Caffo

Società	Posizione	Fine
CANDEL THERAPEUTICS, INC.	Corporate Officer/Principal	01/04/2023
ALX ONCOLOGY HOLDINGS INC.	Corporate Officer/Principal	01/09/2020
Presage Biosciences, Inc. Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of novel drugs for treatment of cancers	Amministratore Delegato	17/07/2018

Vedi nel dettaglio l'esperienza di Nathan Caffo

Formazione di Nathan Caffo

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Nathan Caffo

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	4
Presage Biosciences, Inc. Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of novel drugs for treatment of cancers	Health Technology
The Pennsylvania State University The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Candel Therapeutics, Inc. Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer	Health Technology
ALX Oncology Holdings, Inc. ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer	Health Technology